In the pharmaceutical industry, Aceclofenac is classified as a potent Non-Steroidal Anti-Inflammatory Drug (NSAID) of the phenylacetic acid group. As a pharmacist and manufacturer, I view it as an evolution of Diclofenac—specifically modified to be “strong” enough for chronic inflammatory pain while being significantly gentler on the gastric mucosa.
At your WHO-GMP facility in Mumbai, Aceclofenac is likely a top-tier SKU in your orthopedic and rheumatology portfolios. Its ability to achieve high concentrations in synovial fluid makes it a “strong” choice for joint-specific pain.
Analgesic Strength & Comparison
Aceclofenac is considered a highly effective analgesic, particularly for musculoskeletal and inflammatory pain.
| Comparator | Relative Strength & Profile |
| vs. Paracetamol | Significantly stronger; Aceclofenac provides superior relief for inflammatory conditions like arthritis. |
| vs. Diclofenac | Comparable in potency ($100\text{ mg}$ Aceclofenac $\approx$ $75\text{ mg}$ Diclofenac), but often preferred for better patient compliance and lower GI withdrawal rates. |
| vs. Naproxen | Similar efficacy in chronic conditions (OA/RA), but Aceclofenac typically has a faster onset of action. |
Mechanism: Preferential COX-2 Inhibition
Aceclofenac is a “preferential” COX-2 inhibitor, which is the secret to its balanced strength and safety profile.
Enzyme Targeting: It primarily blocks the COX-2 enzyme, which is responsible for producing the prostaglandins that cause pain and swelling at the site of injury.
Gastric Sparing: Because it has less effect on the COX-1 enzyme (which protects the stomach lining), it is “strong” on pain but “weak” on causing stomach ulcers compared to traditional NSAIDs.
Chondroprotection: Unique to Aceclofenac, it may stimulate the synthesis of glycosaminoglycans in the cartilage, potentially slowing joint degradation in osteoarthritis—a major advantage over many other “strong” painkillers.
The Pharmacist’s “Technical Warning”
The “Cardio” Caution: Like all COX-2 preferential drugs, long-term high doses may increase the risk of cardiovascular events (heart attack/stroke). Use with caution in patients with pre-existing heart conditions.
Renal Monitoring: Chronic use can impair kidney function, particularly in the elderly or those on diuretics. Regular monitoring of renal parameters is mandatory for long-term therapy.
Asthma Trigger: It can trigger “Aspirin-sensitive asthma.” Always screen patients for a history of NSAID-induced bronchospasm.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “FDC” USP: On your marketplace, highlight your Aceclofenac + Paracetamol or Aceclofenac + Serratiopeptidase combinations. These are the “Gold Standard” for post-operative and trauma pain in the Indian and SE Asian markets.
Stability for Export: Aceclofenac is stable but sensitive to moisture. Utilizing Alu-Alu blister packaging is essential for maintaining a 36-month shelf life in Zone IVb tropical regions.
Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international orthopedic and pain management tenders.